Matches in Wikidata for { <http://www.wikidata.org/entity/Q92562994> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q92562994 description "2020 թվականի հունվարի 10-ին հրատարակված գիտական հոդված" @default.
- Q92562994 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92562994 description "scientific article published on 10 January 2020" @default.
- Q92562994 description "wetenschappelijk artikel" @default.
- Q92562994 description "наукова стаття, опублікована 10 січня 2020" @default.
- Q92562994 name "64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First US Prospective, Reader-Blinded Clinical Trial" @default.
- Q92562994 name "64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First US Prospective, Reader-Blinded Clinical Trial" @default.
- Q92562994 type Item @default.
- Q92562994 label "64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First US Prospective, Reader-Blinded Clinical Trial" @default.
- Q92562994 label "64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First US Prospective, Reader-Blinded Clinical Trial" @default.
- Q92562994 prefLabel "64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First US Prospective, Reader-Blinded Clinical Trial" @default.
- Q92562994 prefLabel "64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First US Prospective, Reader-Blinded Clinical Trial" @default.
- Q92562994 P1433 Q92562994-FCE8E822-C7EA-4039-AAEC-6FC090B2BD9C @default.
- Q92562994 P1476 Q92562994-D46DBD41-736A-44E9-B99A-E77B0552E747 @default.
- Q92562994 P2093 Q92562994-0F088D4E-F2DB-48EA-8B94-D3B0511A6115 @default.
- Q92562994 P2093 Q92562994-29010EBB-DBFA-4FA3-AC92-FBD1B621BA79 @default.
- Q92562994 P2093 Q92562994-93EF10FC-245F-41CD-871B-E2F724938AED @default.
- Q92562994 P2093 Q92562994-A17770BF-6169-4CBA-97FB-DE96727DA165 @default.
- Q92562994 P2093 Q92562994-B7391111-B1CF-4382-B0DF-4A1BD33A133F @default.
- Q92562994 P2093 Q92562994-B979B7E5-6FA7-4C8C-8AB5-99093F7EC2AA @default.
- Q92562994 P2093 Q92562994-C3650B44-388E-42DB-AD36-924D8EE9265E @default.
- Q92562994 P2093 Q92562994-CAB80BE3-99CD-49D5-97B3-D3175657E4ED @default.
- Q92562994 P31 Q92562994-528D6ECF-393F-46A8-9C4E-53C2979A9954 @default.
- Q92562994 P356 Q92562994-FBD012E9-6DD6-4F04-9790-EE14611F18BF @default.
- Q92562994 P407 Q92562994-18B79878-B357-41A3-950D-61C3B12D807B @default.
- Q92562994 P50 Q92562994-487C72B2-BB4A-498F-A117-A5396DB712FA @default.
- Q92562994 P577 Q92562994-278BA2F5-BF92-4E7D-B351-4B356D4F9D04 @default.
- Q92562994 P698 Q92562994-41D24916-A730-47B4-9255-B8E0193FE603 @default.
- Q92562994 P356 JNUMED.119.236091 @default.
- Q92562994 P698 31924723 @default.
- Q92562994 P1433 Q7743608 @default.
- Q92562994 P1476 "64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First US Prospective, Reader-Blinded Clinical Trial" @default.
- Q92562994 P2093 "Afshin Shafie" @default.
- Q92562994 P2093 "Ali Abbasi" @default.
- Q92562994 P2093 "Ayman Gaber" @default.
- Q92562994 P2093 "David Ranganathan" @default.
- Q92562994 P2093 "Ebrahim S Delpassand" @default.
- Q92562994 P2093 "Izabela Tworowska" @default.
- Q92562994 P2093 "Nilesh Wagh" @default.
- Q92562994 P2093 "Rodolfo Núñez" @default.
- Q92562994 P31 Q13442814 @default.
- Q92562994 P356 "10.2967/JNUMED.119.236091" @default.
- Q92562994 P407 Q1860 @default.
- Q92562994 P50 Q39183738 @default.
- Q92562994 P577 "2020-01-10T00:00:00Z" @default.
- Q92562994 P698 "31924723" @default.